patholog
studi
fatal
case
caus
pandem
influenza
viru
report
extens
diffus
alveolar
damag
viru
infect
predominantli
lung
parenchyma
howev
host
immun
respons
sever
infect
poorli
understood
herein
investig
viral
load
immun
respons
apoptosi
lung
tissu
fatal
case
viru
infect
result
suggest
cytokineschemokin
show
remark
high
express
includ
receptor
antagonist
protein
tumor
necrosi
factora
monocyt
chemoattract
macrophag
inflammatori
protein
interferoninduc
lung
tissu
fatal
case
viral
load
show
highest
level
day
ill
onset
persist
day
ill
posit
correl
mrna
level
receptor
antagonist
protein
monocyt
chemoattract
macrophag
inflammatori
protein
interferoninduc
regul
activ
normal
tcell
express
secret
apoptosi
evid
lung
tissu
stain
tunel
assay
decreas
fa
elev
fasl
mrna
level
present
lung
tissu
cleav
frequent
seen
pneumocyt
submucos
gland
lymphoid
tissu
pathogenesi
viru
infect
associ
viral
replic
product
proinflammatori
mediat
fasl
involv
pathway
virusinduc
apoptosi
lung
tissu
disequilibrium
fa
fasl
level
lung
tissu
could
contribut
delay
clearanc
viru
subsequ
patholog
damag
j
pathol
http
influenza
virus
caus
recurr
epidem
substanti
human
morbid
mortal
influenza
pandem
worst
pandem
record
histori
kill
million
peopl
worldwid
emerg
pandem
influenza
viru
brought
renew
concern
strategi
prevent
control
treatment
reduct
social
human
cost
influenza
diseas
viru
identifi
caus
outbreak
respiratori
tract
infect
begin
spring
time
world
health
organ
declar
pandem
august
viru
spread
countri
death
report
worldwid
http
wwwwhoint
last
access
august
infect
patholog
distinct
season
influenza
viru
infect
previou
influenza
pandem
patholog
evalu
respiratori
tract
tissu
influenzaassoci
death
suggest
mark
differ
exist
viral
tropism
tissu
damag
compar
season
influenza
viru
infect
studi
previou
pandem
death
conclud
death
like
due
viral
infect
concurr
secondari
bacteri
pneumonia
signific
proport
fatal
case
show
sever
pneumonia
histopatholog
studi
viru
infect
show
extens
diffus
alveolar
damag
consist
find
viru
predominantli
infect
lung
parenchyma
addit
fatal
case
mainli
young
middleag
patient
fatal
case
underli
medic
condit
previou
studi
suggest
inadvert
host
immunolog
respons
play
import
role
pathogenesi
sarscov
infect
recent
studi
suggest
viru
could
induc
higher
level
proinflammatori
cytokin
lung
infect
mice
compar
mice
infect
season
influenza
viru
moreov
serolog
studi
show
type
helper
tcell
cytokin
usual
associ
cellmedi
immun
commonli
link
pathogenesi
autoimmuneinflammatori
diseas
could
earli
host
respons
signatur
sever
infect
howev
role
host
immun
respons
human
lung
tissu
regard
sever
respiratori
tract
pathogenesi
infect
remain
unexplor
present
studi
investig
viral
load
immun
respons
induct
apoptosi
lung
tissu
fatal
case
result
suggest
pathogenesi
viral
infect
associ
viral
replic
product
proinflammatori
mediat
addit
fasl
involv
apoptot
process
frequent
observ
lung
airway
tissu
fatal
case
disequilibrium
fa
fasl
level
lung
could
contribut
delay
clearanc
viru
subsequ
patholog
damag
unfix
fresh
frozen
tissu
addit
formalinfix
tissu
avail
case
studi
case
evalu
viral
load
assay
case
fresh
tissu
inform
avail
ill
durat
bioplex
cytokin
assay
biorad
hercul
ca
perform
case
use
viral
load
assay
case
limit
lung
tissu
avail
bioplex
assay
case
base
avail
fresh
lung
tissu
exclud
long
durat
ill
day
pregnanc
histori
immunosuppress
quantit
rtpcr
assay
determin
mrna
level
cytokin
apoptosisassoci
gene
perform
case
lung
tissu
avail
evalu
viru
pcr
posit
lung
tissu
immunostain
assay
local
cytokin
perform
formalinfix
paraffinembed
ffpe
tissu
case
high
cytokin
level
determin
bioplex
assay
two
case
demonstr
extens
posit
immunostain
influenza
nucleoprotein
lung
section
formalinfix
tissu
avail
evalu
control
group
consist
normal
lung
tissu
specimen
normal
group
lung
tissu
normal
group
obtain
biopsi
tissu
archiv
human
tissu
procur
servic
patholog
laboratori
medicin
emori
univers
school
medicin
atlanta
ga
tissu
identifi
normal
lung
tissu
routin
h
e
stain
patholog
chang
ill
condit
includ
inflamm
tumor
observ
tissu
freshfrozen
tissu
fatal
case
evalu
center
diseas
control
prevent
realtim
rtpcr
protocol
determin
whether
tissu
posit
tissu
fix
buffer
formalin
process
paraffin
embed
stain
h
e
histopatholog
examin
ffpe
lung
tissu
special
stain
includ
lillietwort
gram
stain
warthinstarri
silver
impregn
stain
use
determin
presenc
bacteri
infect
describ
previous
publish
studi
ihc
perform
detect
influenza
viru
group
streptococcu
streptococcu
pyogen
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
describ
previous
broadrang
eubacteri
pcr
assay
target
rrna
gene
convent
singlestag
nest
pcr
assay
pneumonia
pyogen
h
influenza
perform
use
dna
extract
ffpe
lung
tissu
specimen
casepati
amplifi
pcr
product
sequenc
autom
ceq
dna
sequenc
beckman
coulter
fullerton
ca
confirm
bacteri
agent
cytokin
chemokin
protein
level
frozen
lung
tissu
assess
prohuman
cytokin
beadbas
cytokin
assay
biorad
cytokin
test
follow
receptor
antagonist
protein
eotaxin
basic
fibroblast
growth
factor
granulocyt
colonystimul
factor
granulocytemacrophag
colonystimul
factor
interferong
monocyt
chemoattract
macrophag
inflammatori
protein
human
plateletderiv
growth
factor
bb
chemokin
activ
normal
tcell
express
secret
rant
tumor
necrosi
factor
tnf
vascular
endotheli
growth
factor
interferoninduc
base
clinic
laboratori
find
case
evalu
assay
group
divid
two
group
nonbacteri
coinfect
group
n
z
bacteri
coinfect
group
n
z
furthermor
normal
lung
tissu
previous
mention
use
assay
normal
group
frozen
lung
tissu
homogen
cell
lysi
buffer
biorad
contain
proteas
inhibitor
mixtur
mintab
roch
appli
scienc
indianapoli
use
tissu
weight
mg
lysi
buffer
volum
ml
ratio
homogen
lyse
altern
freez
c
thaw
cycl
sonic
minut
ice
follow
centrifug
g
minut
c
sampl
ml
supernat
use
measur
cytokin
level
use
bioplex
pro
human
cytokin
assay
kit
biorad
accord
manufactur
instruct
use
bioplex
array
reader
biorad
sampl
run
duplic
data
acquisit
bioplex
manag
softwar
version
use
biorad
rna
extract
freshfrozen
lung
tissu
use
rneasi
plu
mini
kit
qiagen
hilden
germani
per
kit
protocol
briefli
approxim
mg
lung
tissu
differ
lobe
lyse
buffer
rlt
qiagen
rna
obtain
volum
genom
dna
remov
use
genom
dna
spin
column
store
c
use
vitro
transcrib
rna
matrix
gene
human
cytokin
includ
tnfa
apoptosisassoci
gene
fa
fasl
tnfrelat
apoptosisinduc
ligand
trail
use
determin
detect
limit
assay
intern
posit
control
recombin
plasmid
contain
matrix
gene
linear
restrict
enzym
ecori
purifi
use
qiagen
dna
cleanup
kit
dna
concentr
measur
od
unit
nm
cytokin
apoptosisassoci
gene
segment
amplifi
specif
primer
promot
sequenc
termin
end
linear
plasmid
dna
purifi
pcr
product
cytokin
mg
apoptosisassoci
gene
segment
transcrib
use
riboprob
vitro
transcript
system
kit
promega
madison
wi
promot
accord
manufactur
instruct
transcrib
rna
purifi
quantifi
copi
number
normal
use
human
housekeep
gene
purifi
total
rna
extract
cell
use
quantifi
influenza
viral
load
cytokin
mrna
apoptosisassoci
mrna
express
lung
tissu
realtim
quantit
rtpcr
rtqpcr
perform
use
qpcr
detect
system
agil
technolog
inc
santa
clara
ca
use
fluoresc
label
taqman
probe
enabl
continu
monitor
amplicon
format
primer
probe
influenza
matrix
gene
previous
describ
cytokin
tnfa
apoptosisassoci
fa
fasl
trail
primer
probe
use
studi
previous
publish
assay
perform
total
volum
ml
use
quantitect
probe
pcr
kit
qiagen
ml
total
rna
mmoll
primer
mmoll
probe
thermal
cycl
condit
use
assay
follow
revers
transcript
c
minut
cycl
c
minut
cycl
c
second
c
second
c
second
standard
curv
gener
use
serial
dilut
vitro
transcrib
standard
rna
approxim
copi
cell
rna
approxim
pg
ng
tunel
stain
use
situ
detect
apoptosi
ffpe
lung
tissu
fatal
case
detect
perform
deparaffin
ffpe
section
mm
thick
cell
death
tunel
pod
detect
system
roch
accord
manufactur
instruct
intern
posit
control
consist
ffpe
section
taken
human
colon
tissu
biocar
medic
concord
ca
assess
cytokin
distribut
respiratori
tract
tissu
ihc
perform
deparaffin
ffpe
section
mm
ajpamjpatholorg
american
journal
patholog
thick
use
monoclonalpolyclon
antibodi
r
system
minneapoli
mn
santa
cruz
biotechnolog
dalla
tx
thermo
scientif
waltham
cleav
biocar
medic
use
polymerbas
colorimetr
indirect
immunoalkalin
phosphatas
method
posit
control
consist
human
colon
tissu
cleav
lymphocyt
treat
phytohemagglutinin
lipopolysaccharid
neg
control
consist
sequenti
case
patient
tissu
section
incub
normal
mous
rabbit
serum
pertin
primari
antibodi
antibodypolym
conjug
visual
appli
fast
red
chromogen
labvis
waltham
dissolv
naphthol
phosphat
substrat
buffer
tissu
section
block
experi
describ
previou
report
perform
confirm
specif
brief
antibodi
previous
mention
incub
ngml
recombin
human
hour
c
diluent
buffer
contain
trisbuff
normal
mous
triton
untreat
preabsorb
antibodi
use
primari
antibodi
incub
normal
lung
tissu
neg
control
cell
control
posit
control
lung
tissu
previous
mention
quantit
cytokinechemokin
profil
apoptosisassoci
gene
mrna
level
viral
load
compar
utest
kruskalw
test
correl
viral
load
quantit
proinflammatori
factor
analyz
pearson
correl
test
differ
consid
signific
p
twotail
test
analysi
perform
use
instat
vision
version
graphpad
prism
la
jolla
ca
demograph
data
case
summar
tabl
median
age
patient
year
interquartil
rang
month
year
mean
age
year
fortythre
patient
age
rang
year
twentyeight
patient
femal
addit
patient
document
histori
underli
medic
condit
includ
asthma
obes
pregnanc
immunosuppress
complic
shown
figur
viral
load
correl
durat
ill
p
z
rel
high
viral
load
present
earli
stage
ill
peak
day
ill
could
detect
late
day
ill
onset
american
journal
pathologyajpamjpatholorg
p
z
p
z
respect
compar
nonbacteri
coinfect
group
rant
significantli
higher
group
p
z
analyz
correl
viral
load
host
respons
freshfrozen
lung
tissu
influenza
realtim
pcrposit
case
test
use
rtqpcr
assay
design
quantifi
express
level
immun
mediat
mrna
includ
tnfa
rant
pearson
correl
test
suggest
shown
figur
viral
load
posit
correl
rant
correl
coeffici
rang
p
z
supplement
tabl
tnfa
mrna
level
significantli
correl
viral
load
p
z
respect
shown
figur
fasl
mrna
level
lung
tissu
fatal
case
remark
higher
normal
lung
control
p
z
addit
fasl
mrna
level
posit
correl
viral
load
lung
tissu
p
z
figur
supplement
tabl
howev
low
fa
mrna
level
detect
lung
tissu
case
compar
normal
group
result
significantli
lower
fa
mrna
level
p
z
furthermor
tnfrelat
apoptosisinduc
ligand
trail
mrna
level
significantli
differ
two
group
p
z
mention
previou
report
figur
specif
antibodi
demonstr
block
assay
posit
case
use
correspond
recombin
protein
figur
l
normal
lung
tissu
neg
control
figur
immun
mediatorproduc
cell
detect
lung
submucos
tissu
vari
degre
distribut
immunostain
individu
cytokin
viral
antigen
perform
use
consecut
section
viral
antigen
local
similar
area
within
pneumocyt
submucos
gland
patient
bacteri
coinfect
figur
gen
similar
result
observ
nonecoinfect
patient
photomicrograph
shown
figur
patient
coinfect
woman
clinic
cours
infect
group
streptococcu
coinfect
girl
durat
ill
pneumonia
coinfect
ihc
assay
demonstr
promin
express
cleav
submucos
gland
figur
pneumocyt
epitheli
cell
area
bronchopneumonia
figur
c
e
alveoli
figur
lymphoid
tissu
figur
tunel
stain
suggest
apoptot
cell
extens
present
lung
airway
apoptot
bodi
correspond
cleav
immunostain
submucos
gland
figur
pneumocyt
epithelia
area
bronchopneumonia
figur
f
alveolar
pneumocyt
figur
lymphoid
tissu
figur
consecut
tissu
section
fatal
case
viru
infect
present
differ
characterist
season
influenza
viru
infect
includ
age
distribut
pattern
respect
morbid
lung
patholog
characterist
season
influenza
american
journal
pathologyajpamjpatholorg
viru
infect
replic
viru
respiratori
tract
directli
injur
nasal
tracheobronchi
epithelium
associ
virusinduc
cellular
apoptosi
result
involv
respiratori
tract
epitheli
cell
one
major
reason
sever
manifest
accompani
infect
cough
depress
tracheobronchi
clearanc
alter
pulmonari
function
infect
also
elicit
cascad
host
immun
defens
lead
local
inflamm
influx
polymorphonuclear
cell
lymphocyt
macrophag
respiratori
tract
mucosa
lung
although
respons
lead
resolut
infect
protect
reinfect
like
also
contribut
develop
local
system
symptom
addit
tradit
well
document
danger
host
gener
infect
influenza
viru
predispos
secondari
infect
bacteri
pathogen
studi
design
evalu
role
viral
load
distribut
cytokin
respons
apoptosi
pathogenesi
viru
infect
clinic
signific
prolong
viral
shed
rel
late
peak
viral
kinet
complet
understood
studi
suggest
initi
nasopharyng
endotrach
viral
load
peak
day
symptom
onset
irrespect
diseas
sever
prolong
viral
shed
present
howev
patholog
studi
viru
infect
show
viru
predominantli
infect
lung
parenchyma
knowledg
viral
load
viral
shed
lung
tissu
yet
suffici
assess
present
studi
result
show
viral
load
lung
tissu
detect
late
day
onset
ill
peak
day
onset
find
could
relat
viral
infect
lung
parenchyma
patient
pneumonia
higher
viral
load
bronchiti
upper
respiratori
tract
infect
could
also
explain
less
studi
demonstr
remark
elev
tnfa
fatal
case
correl
peak
viral
load
lung
tissu
interestingli
mrna
level
posit
correl
viral
load
although
present
signific
level
lung
tissu
fatal
case
result
could
explain
natur
function
influenza
potent
promot
polymorphonuclear
cell
movement
blood
tissu
cell
releas
mediat
harm
may
persist
rel
long
period
stimul
howev
potenti
mediat
measur
symptom
sign
influenza
infect
addit
unlik
previou
season
influenza
studi
rant
level
fatal
case
significantli
differ
normal
lung
group
howev
viral
load
posit
correl
rant
mrna
level
lung
tissu
thu
reason
assum
viru
may
effect
induc
rant
express
lung
mrna
detect
extens
correspond
cytokin
play
physiolog
role
viral
infect
rant
chemokin
play
activ
role
recruit
leukocyt
inflammatori
site
induc
prolifer
activ
certain
natur
killer
cell
form
chemokineactiv
killer
cell
previou
studi
shown
rant
associ
increas
effici
viruscel
fusion
tnfa
could
specif
associ
bacteri
coinfect
previou
studi
show
elev
tnfa
present
sever
influenza
viru
infect
high
level
correl
system
diseas
symptom
associ
influenza
viru
infect
may
role
initi
measur
symptom
sign
infect
respect
cytokin
studi
agreement
previou
studi
show
cytokin
elev
lung
tissu
howev
stratifi
presenc
bacteri
coinfect
evid
suggest
tnfa
associ
case
bacteri
coinfect
viru
infect
alon
viral
pathogenesi
sever
infect
may
associ
viral
replic
potenti
exacerb
host
immun
respons
previous
publish
studi
suggest
parenchym
lung
involv
viru
similar
histopatholog
featur
viral
local
seen
fatal
human
casepati
highli
pathogen
avian
influenza
studi
suggest
cytokin
storm
occur
highli
pathogen
avian
influenza
case
high
virul
viru
associ
increas
host
respons
howev
viru
thought
less
virul
viru
induc
mild
ill
infect
person
studi
evid
suggest
virusinduc
immun
respons
present
lung
fatal
case
demonstr
increas
level
cytokin
chemokin
includ
tnfa
gener
thought
potent
antiinflammatori
cytokin
howev
balanc
level
local
tissu
influenc
physiolog
pathophysiolog
effect
studi
suggest
vari
inflammatori
effect
level
posit
associ
sever
certain
infecti
diseas
addit
tnfa
previous
mention
play
import
role
innat
immun
respons
crucial
initi
subsequ
direct
adapt
immun
respons
well
promot
local
inflamm
produc
cytokin
recruit
addit
leukocyt
site
infect
howev
unrestrain
excess
stimul
innat
immun
respons
harm
furthermor
level
immun
mediat
lung
posit
correl
viral
load
evid
suggest
viru
replic
effici
achiev
high
viral
load
lung
earli
stage
infect
immunostain
individu
cytokin
viral
antigen
perform
consecut
section
show
viral
antigen
local
similar
area
within
lung
submucos
gland
monokin
detect
small
cell
within
alveolar
wall
larger
cell
alveolar
air
space
wherea
lymphokin
seen
mainli
small
cell
locat
within
alveolar
wall
present
cytokineschemokin
consist
document
result
immun
cell
extens
present
lung
tissu
may
activ
complement
system
lung
tissu
fatal
case
result
exacerb
host
immun
respons
taken
togeth
conclud
viru
replic
effici
lung
viral
pathogenesi
relat
viral
replic
product
proinflammatori
mediat
apoptosi
obviou
lung
fatal
case
fasl
involv
apoptot
pathway
influenzainduc
apoptosi
found
varieti
cell
type
vitro
vivo
howev
precis
mechan
virusinduc
apoptosi
unclear
current
two
major
pathway
apoptosi
induct
intrins
pathway
regul
activ
interact
member
famili
postul
host
defens
mechan
stop
replic
spread
viru
extrins
pathway
apoptosi
trigger
certain
tnf
famili
member
engag
respect
cognat
receptor
surfac
target
cell
addit
tnf
trail
fa
fasl
belong
subfamili
ligand
respons
extrins
induct
cell
death
result
suggest
apoptosi
present
lung
tissu
fatal
case
mrna
level
fasl
gene
posit
correl
viral
load
remark
elev
lung
tissu
howev
trail
mrna
level
significantli
increas
addit
express
fa
gene
inhibit
lung
tissu
anim
model
studi
suggest
fasl
involv
viral
clearanc
develop
immunopatholog
characterist
respiratori
tract
viru
infect
mice
defici
function
fasl
exhibit
reduc
morbid
influenza
viru
infect
compar
wildtyp
mice
howev
result
suggest
fatal
human
case
elev
fasl
level
trigger
induct
apoptosi
lung
tissu
result
sever
patholog
characterist
disequilibrium
fa
fasl
could
delay
viral
clearanc
addit
common
event
pathway
influenza
virusinduc
apoptosi
activ
set
cystein
proteas
caspas
studi
coloc
cleav
apoptot
bodi
seen
lung
airway
fatal
case
although
express
subtyp
caspas
studi
result
indic
involv
pathway
apoptosi
fatal
case
conclus
investig
viral
load
immun
respons
apoptosi
associ
autopsi
lung
tissu
fatal
case
result
indic
viral
load
prolong
viral
shed
peak
day
ill
onset
lung
tissu
induc
exacerb
local
immun
respons
apoptosi
pathogenesi
viru
infect
associ
viral
replic
product
proinflammatori
mediat
respiratori
tract
tissu
addit
fasl
involv
pathway
virusinduc
apoptosi
lung
tissu
disequilibrium
fa
fasl
level
lung
could
contribut
delay
clearanc
viru
patholog
damag
consider
implic
develop
clinic
treatment
strategi
ajpamjpatholorg
american
journal
patholog
